Doctors and hospitals are noticing a clear shift: more people are choosing medications over operations to tackle obesity. As GLP‑1 drugs like semaglutide gain popularity, traditional weight‑loss surgeries are being scheduled less often. The change is reshaping clinical practice, insurance decisions, and patient expectations. Why surgery rates are dropping as …